Position in NPCE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$503,140
+$115,926 QoQ
Shares Held
31,664
+7.5% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 112 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in NPCE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,264,483,794 across 83 Medical Devices names. NPCE ranks #52 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in NPCE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $503,140 | 31,664 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $387,214 | 29,446 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $452,500 | 29,307 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $330,260 | 32,033 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $411,689 | 36,956 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $211,719 | 17,227 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $167,402 | 14,960 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $99,852 | 14,326 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $110,859 | 14,664 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||